Delphi Ventures

Menlo Park, United States
Investments are made in life sciences firms across all stages.

About Delphi Ventures

Delphi Ventures is a Financial Services company based in Menlo Park (United States). Investments are made in life sciences firms across all stages. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.

Company details

A stage-agnostic venture capital firm is operated with a focus on life sciences. Investments are directed toward companies in biopharma, medical devices, biotech, and diagnostics. Operations span the US and Canada, with the firm based in Menlo Park, United States. Portfolio holdings include Intarcia Therapeutics, TriVascular, Karyopharm Therapeutics, PTC Therapeutics, and Relypsa.

Web traffic of Delphi Ventures

Websites that share an audience with Delphi Ventures (delphiventures.com).

Similar websites

Websites whose visitors overlap most with Delphi Ventures. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
franciscopartners.com
79%
47.1K#751,938View details

Top companies in Venture Capital Funds

3 companies that operate in the same segment as Delphi Ventures (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Venture capital firm investing in early-stage tech startups
1972Menlo Park, California, United States
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
1911Redwood City, California, United StatesUSD 691.23 K
Accel is recognized as a leading venture capital firm.
1983Palo Alto, California, United States
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Delphi Ventures

Premium access

Complete news archive for Delphi Ventures

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Delphi Ventures

Delphi Ventures is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

A stage-agnostic venture capital firm is operated with a focus on life sciences. Investments are directed toward companies in biopharma, medical devices, biotech, and diagnostics. Operations span the US and Canada, with the firm based in Menlo Park, United States. Portfolio holdings include Intarcia Therapeutics, TriVascular, Karyopharm Therapeutics, PTC Therapeutics, and Relypsa.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available